跳至主要内容
临床试验/JPRN-jRCT2080223178
JPRN-jRCT2080223178未知1 期

A randomized, open-label, 3-way crossover study to assess the pharmacokinetic drug interactions between DS-8500a and a hypoglycemic agent (glimepiride or repaglinide) in Japanese healthy subjects

DAIICHI SANKYO CO., LTD.0 个研究点目标入组 36 人开始时间: 2016年4月22日最近更新:

试验速览

阶段
1 期
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 45age old(—)
性别
All

入选标准

  • 1)Japanese
  • 2)Persons who provided written informed consent before the screening examination
  • 3)Persons >= 20 years and =< 45 years of age at the time of informed consent
  • 4)Persons with a body mass index (BMI; calculated by body weight [kg]/height [m]2) of >= 18.5 kg/m2 and < 25.0 kg/m2 at the screening examination

排除标准

  • 1)Persons with hypersensitivity or idiosyncratic reactions to a drug, (such as penicillin allergy)
  • 2)Persons with drug or alcohol dependence

研究者

相似试验

A randomized, open-label, 3-way crossover study to... | 临床试验